A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

Rotavirus is the most common cause of moderate-to-severe infant diarrhoea in developing countries, resulting in enormous morbidity, mortality, and economic burden. A bovine-human reassortant pentavalent rotavirus vaccine (BRV-PV) targeting the globally most common strains was developed in India and...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Vaccine
المؤلفون الرئيسيون: Kulkarni, Prasad S., Desai, Sajjad, Tewari, Tushar, Kawade, Anand, Goyal, Nidhi, Garg, Bishan Swarup, Kumar, Dinesh, Kanungo, Suman, Kamat, Veena, Kang, Gagandeep, Bavdekar, Ashish, Babji, Sudhir, Juvekar, Sanjay, Manna, Byomkesh, Dutta, Shanta, Angurana, Rama, Dewan, Deepika, Dharmadhikari, Abhijeet, Zade, Jagdish K., Dhere, Rajeev M., Fix, Alan, Power, Maureen, Uprety, Vidyasagar, Parulekar, Varsha, Cho, Iksung, Chandola, Temsunaro R., Kedia, Vikash K., Raut, Abhishek, Flores, Jorge
التنسيق: Artigo
اللغة:Inglês
منشور في: Elsevier Science 2017
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC5651219/
https://ncbi.nlm.nih.gov/pubmed/28967523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2017.09.014
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة